ABL, a global contract research and manufacturing service provider to the U.S. Government and biopharmaceutical industry, has been awarded a five-year, indefinite delivery/indefinite quantity (ID/IQ) contract #HHSO100201600019I entitled, “Respiratory Illness Live Virus Fill/Finish Services,” by the Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HH...